Original Research
Accepted on 08 Sep 2025
Pressure enabled drug delivery (PEDD) of nelitolimod increased therapeutic delivery, reduced immunosuppression, and improved efficacy in porcine and murine liver tumor models
in Cancer Immunity and Immunotherapy